Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Menactra Vaccine

Prescription Icon
Prescription Required

Marketer

Sanofi India Ltd

Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135) (16mcg) + Diphtheria Toxoid (48mcg)

Overview Menactra Vaccine

Meningococcal disease prevention is achieved through the Menactra vaccine. This vaccine provides active immunity against invasive disease caused by *Neisseria meningitidis* serogroups A, C, Y, and W-135. It's licensed for individuals aged 9 months to 55 years. Administration must be by a qualified healthcare provider; self-injection is strictly prohibited. A complete vaccination course is crucial for optimal protection. A single booster shot might be recommended for those aged 15 to 55 who remain at high risk, provided at least 4 to 6 years have passed since the previous dose. Intravenous, subcutaneous, or intradermal administration is contraindicated. Common reactions include injection site discomfort (pain, swelling, redness), fussiness, decreased appetite, drowsiness, headache, nausea, vomiting, and diarrhea. Persistent or worsening side effects warrant medical attention; management strategies may be available. Prior to vaccination, disclose any pre-existing conditions or medications to your physician to ensure safety. Pregnant or breastfeeding individuals should consult their doctor before vaccination.

Uses of Menactra Vaccine

Averting Meningococcal Infection

Major Benefits of Menactra Vaccine:

Your healthcare provider will instruct you on the proper administration of this medication.

Common Side effects of Menactra Vaccine:

  • Irritability
  • Injection site reactions (pain, swelling, redness)
  • Loss of appetite
  • Sleepiness
  • Headache
  • Nausea
  • Vomiting
  • Diarrhea
  • Erythema (skin redness)

How to use Menactra Vaccine:

Your healthcare provider will instruct you on the proper administration of this medication.

How Menactra Vaccine works:

Menactra is a vaccine formulated with polysaccharides from serogroups A, C, Y, and W-135 of the meningococcal bacteria. Diphtheria toxoid protein serves as a carrier for these individual polysaccharide antigens. The vaccine triggers a minor, non-disease-causing immune response, prompting antibody production to safeguard against subsequent meningococcal infections.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Menactra vaccination presents an unknown safety profile. Physician consultation is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Menactra Vaccine during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice from your doctor.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Menactra vaccine administration while breastfeeding is currently lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Menactra Vaccine's effect on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Menactra vaccine administration to individuals with renal impairment. Seek medical advice from your physician.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Menactra vaccine administration to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Menactra Vaccine :

NA

Facts to Know About Menactra Vaccine

LabelValue
Developing Habits No.
Treatment Category Immunizations
Menactra Vaccine
6,156